Matsueda S - Search Results

1

Feasibility study of personalized peptide vaccination for metastatic recurrent triple-negative breast cancer patients.

Takahashi R, Toh U, Iwakuma N, Takenaka M, Otsuka H, Furukawa M, Fujii T, Seki N, Kawahara A, Kage M, Matsueda S, Akagi Y, Yamada A, Itoh K, Sasada T. Takahashi R, et al. Among authors: matsueda s. Breast Cancer Res. 2014 Jul 3;16(4):R70. doi: 10.1186/bcr3685. Breast Cancer Res. 2014. PMID: 24992895 Free PMC article. Clinical Trial.

2

Phase II study of personalized peptide vaccination for refractory bone and soft tissue sarcoma patients.

Takahashi R, Ishibashi Y, Hiraoka K, Matsueda S, Kawano K, Kawahara A, Kage M, Ohshima K, Yamanaka R, Shichijo S, Shirouzu K, Itoh K, Sasada T. Takahashi R, et al. Among authors: matsueda s. Cancer Sci. 2013 Oct;104(10):1285-94. doi: 10.1111/cas.12226. Epub 2013 Aug 6. Cancer Sci. 2013. PMID: 23829867 Free PMC article. Clinical Trial.

3

Phase II study of personalized peptide vaccination for previously treated advanced colorectal cancer.

Kibe S, Yutani S, Motoyama S, Nomura T, Tanaka N, Kawahara A, Yamaguchi T, Matsueda S, Komatsu N, Miura M, Hinai Y, Hattori S, Yamada A, Kage M, Itoh K, Akagi Y, Sasada T. Kibe S, et al. Among authors: matsueda s. Cancer Immunol Res. 2014 Dec;2(12):1154-62. doi: 10.1158/2326-6066.CIR-14-0035. Epub 2014 Oct 28. Cancer Immunol Res. 2014. PMID: 25351849 Clinical Trial.

4

Identification of HER2/ neu-derived peptides capable of inducing both cellular and humoral immune responses in HLA-A24 positive breast cancer patients.

Azuma K, Shichijo S, Shomura H, Matsueda S, Fujii T, Itoh K. Azuma K, et al. Among authors: matsueda s. Breast Cancer Res Treat. 2004 Jul;86(1):19-29. doi: 10.1023/B:BREA.0000032920.95410.63. Breast Cancer Res Treat. 2004. PMID: 15218358

5

Phase II study of personalized peptide vaccination for castration-resistant prostate cancer patients who failed in docetaxel-based chemotherapy.

Noguchi M, Moriya F, Suekane S, Matsuoka K, Arai G, Matsueda S, Sasada T, Yamada A, Itoh K. Noguchi M, et al. Among authors: matsueda s. Prostate. 2012 Jun 1;72(8):834-45. doi: 10.1002/pros.21485. Epub 2011 Sep 19. Prostate. 2012. PMID: 21932426 Clinical Trial.

6

Personalized peptide vaccination in patients with refractory non-small cell lung cancer.

Yoshiyama K, Terazaki Y, Matsueda S, Shichijo S, Noguchi M, Yamada A, Mine T, Ioji T, Itoh K, Shirouzu K, Sasada T, Takamori S. Yoshiyama K, et al. Among authors: matsueda s. Int J Oncol. 2012 May;40(5):1492-500. doi: 10.3892/ijo.2012.1351. Epub 2012 Feb 1. Int J Oncol. 2012. PMID: 22307435 Clinical Trial.

7

Immunological evaluation of personalized peptide vaccination in refractory small cell lung cancer.

Terazaki Y, Yoshiyama K, Matsueda S, Watanabe N, Kawahara A, Naito Y, Suekane S, Komatsu N, Ioji T, Yamada A, Mine T, Terasaki M, Itoh K, Takamori S, Sasada T. Terazaki Y, et al. Among authors: matsueda s. Cancer Sci. 2012 Apr;103(4):638-44. doi: 10.1111/j.1349-7006.2012.02202.x. Epub 2012 Feb 13. Cancer Sci. 2012. PMID: 22321067 Free PMC article. Clinical Trial.

8

A phase II study of a personalized peptide vaccination for chemotherapy-resistant advanced pancreatic cancer patients.

Yutani S, Komatsu N, Yoshitomi M, Matsueda S, Yonemoto K, Mine T, Noguchi M, Ishihara Y, Yamada A, Itoh K, Sasada T. Yutani S, et al. Among authors: matsueda s. Oncol Rep. 2013 Sep;30(3):1094-100. doi: 10.3892/or.2013.2556. Epub 2013 Jun 20. Oncol Rep. 2013. PMID: 23784011 Clinical Trial.

9

A phase II trial of personalized peptide vaccination in castration-resistant prostate cancer patients: prolongation of prostate-specific antigen doubling time.

Noguchi M, Moriya F, Suekane S, Ohnishi R, Matsueda S, Sasada T, Yamada A, Itoh K. Noguchi M, et al. Among authors: matsueda s. BMC Cancer. 2013 Dec 30;13:613. doi: 10.1186/1471-2407-13-613. BMC Cancer. 2013. PMID: 24373380 Free PMC article. Clinical Trial.

10

Feasibility study of personalized peptide vaccination for recurrent ovarian cancer patients.

Kawano K, Tsuda N, Matsueda S, Sasada T, Watanabe N, Ushijima K, Yamaguchi T, Yokomine M, Itoh K, Yamada A, Kamura T. Kawano K, et al. Among authors: matsueda s. Immunopharmacol Immunotoxicol. 2014 Jun;36(3):224-36. doi: 10.3109/08923973.2014.913617. Epub 2014 Apr 29. Immunopharmacol Immunotoxicol. 2014. PMID: 24773550 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

133 results

Search Page